Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dai Chihara

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|December 17, 2024
The current understanding of chimeric antigen receptor (CAR) T-cell therapy for older patients with relapsed or refractory large B-cell lymphomaKunhwa Kim, Dai Chihara
Expert Review of Hematology|September 7, 2020
Treatment of hairy cell leukemiaDai Chihara, Robert J Kreitman
Hematology/Oncology Clinics of North America|March 26, 2017
Management of Anaplastic Large Cell LymphomaDai Chihara, Michelle A Fanale
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Comparison of the incidence and trends of hematologic malignancies between Japan and the United States]Dai Chihara, Hidemi Ito, Keitaro Matsuo
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Epidemiology of hematologic malignancy in Japan]Dai Chihara, Hidemi Ito, Keitaro Matsuo
British Journal of Haematology|May 12, 2023
Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectivesDai Chihara, Loretta J Nastoupil, Christopher R Flowers
Cancer Science|January 24, 2015
Recent advances in the treatment of adult T-cell leukemia-lymphomasAtae Utsunomiya, Ilseung Choi, Dai Chihara, et al.
Leukemia|March 5, 2021
Targeted based therapy in nodal T-cell lymphomasDai Chihara, Milos Miljkovic, Swaminathan P Iyer, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[An overwhelming post-splenectomy infection with toxic shock syndrome by group B Streptococcus]Dai Chihara, Takashi Sakamoto, Gaku Murakami, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2022
The Impact of Sequence of Therapy for Older Patients With Follicular Lymphoma: SEER-Medicare AnalysisCan Xie, Ruosha Li, Xuelin Huang, et al.
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|December 17, 2024
The current understanding of chimeric antigen receptor (CAR) T-cell therapy for older patients with relapsed or refractory large B-cell lymphomaKunhwa Kim, Dai Chihara
Expert Review of Hematology|September 7, 2020
Treatment of hairy cell leukemiaDai Chihara, Robert J Kreitman
Hematology/Oncology Clinics of North America|March 26, 2017
Management of Anaplastic Large Cell LymphomaDai Chihara, Michelle A Fanale
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Comparison of the incidence and trends of hematologic malignancies between Japan and the United States]Dai Chihara, Hidemi Ito, Keitaro Matsuo
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Epidemiology of hematologic malignancy in Japan]Dai Chihara, Hidemi Ito, Keitaro Matsuo
British Journal of Haematology|May 12, 2023
Clinical approaches for integrating machine learning for patients with lymphoma: Current strategies and future perspectivesDai Chihara, Loretta J Nastoupil, Christopher R Flowers
Cancer Science|January 24, 2015
Recent advances in the treatment of adult T-cell leukemia-lymphomasAtae Utsunomiya, Ilseung Choi, Dai Chihara, et al.
Leukemia|March 5, 2021
Targeted based therapy in nodal T-cell lymphomasDai Chihara, Milos Miljkovic, Swaminathan P Iyer, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[An overwhelming post-splenectomy infection with toxic shock syndrome by group B Streptococcus]Dai Chihara, Takashi Sakamoto, Gaku Murakami, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2022
The Impact of Sequence of Therapy for Older Patients With Follicular Lymphoma: SEER-Medicare AnalysisCan Xie, Ruosha Li, Xuelin Huang, et al.
Pageof 13